结论血清igfbp - 1作为生长抑制因子参与正常胎鼠发育及IUGR的发生。
Conclusions Serum IGFBP-1 participates in the growth of normal and IUGR rat fetuses as an inhibiting factor.
结论含高剂量中药的大鼠血清有抑制血管内皮细胞生长因子诱导内皮细胞增殖的作用。
CONCLUSION the rat serum including high dose herb medicine could have an effect on inhibition of proliferation of endothelial cell induced by vascular ECGF.
家畜早孕因子是妊娠母体血清中最早出现的一种免疫抑制因子。
Early pregnancy factor (EPF) is an immunity inhibition factor which is the earliest emergence in the serum of pregnant body.
结论保肾冲剂血清能抑制MC增殖并能干预活化MC分泌细胞因子。
Conclusion This study indicates that can BSM inhibited MC proliferation and intervene secretion of inflammatory medium of activated MC.
结论尿毒症患者血清中存在红细胞生成抑制因子，其对红系造血祖细胞的抑制作用具有剂量依赖性。
Conclusion The erythropoiesis inhibitors might exist in uremia sera which had a dose-dependent inhibitory effects on CFU-E and BFU-E proliferations.
目的：探讨间接酶联免疫吸附试验（ELISA）检测核糖核酸酶抑制因子（RI）在恶性肿瘤患者血清中的表达。
Objective: To detect the expression of ribonuclease inhibitor (RI) in the serum of patients with malignant tumors by indirect ELISA.
目的观察妇科恶性肿瘤患者血清、腹腔液中巨噬细胞移动抑制因子(MIF)的表达及其与恶性肿瘤的相关性。
Objective to investigate the expressions of macrophage migration inhibitory factor (MIF) in gynecologic malignancy tumor patients and the correlation between VEGF and CA125.
结论大剂量阿托伐他汀调脂治疗，能降低患者血清炎性因子的水平，具有抑制炎症和稳定斑块作用。
Conclusion High-dose atorvastatin could rapidly reduce serum inflammatory factors in patients with acute stroke, thus might inhibit inflammation and stabilize atherosclerotic plaque.
结论：阿托伐他汀能降低ACS患者的血清炎症因子，具有抑制炎症和稳定斑块作用。
Conclusions: Atorvastatin could reduce inflammatory factors in serum of patients with ACS with a role in inhibiting inflammation and plaque stability.
结论：阿托伐他汀能降低ACS患者的血清炎症因子，具有抑制炎症和稳定斑块作用。
Conclusions: Atorvastatin could reduce inflammatory factors in serum of patients with ACS with a role in inhibiting inflammation and plaque stability.
应用推荐